Tolterodine Tartrate
Product Images NDC 10135-706
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tolterodine Tartrate (NDC 10135-706). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Package Label (PRINCIPAL DISPLAY PANEL – 1 mg StrengthNDC 10135-0706-6060 Tablets Tolterodine Tartrate Tablets 1 mg Rx only)
Package Label (PRINCIPAL DISPLAY PANEL – 1 mg StrengthNDC 10135-0706-05500 Tablets Tolterodine Tartrate Tablets 1 mg Rx only)
Package Label (PRINCIPAL DISPLAY PANEL – 2 mg StrengthNDC 10135-0707-6060 Tablets Tolterodine Tartrate Tablets 2 mg Rx only)
Package Label (PRINCIPAL DISPLAY PANEL – 2 mg StrengthNDC 10135-0707-05500 Tablets Tolterodine Tartrate Tablets 2 mg Rx only)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.